WTW Willis Towers Watson
Quality broker priced near 320 is now over twice book-based value; fundamentals are unchanged, so discipline holds.
The story
WTW is an asset-light, fee-based broker and consulting franchise with sticky corporate clients, low credit risk and recurring revenue. Operating margin has recovered to 22.8% after the prior year's one-off hit, and trailing ROE of 19.6% sits in line with the normalized level I already used. Book equity is mostly goodwill and is kept small by steady buybacks, so a book-based residual income model will undervalue this business against a market that prices it on fee earnings.
I'm keeping the drivers unchanged. Trailing ROE of 19.6% confirms 19% as a sustainable through-the-cycle level, but I won't extrapolate a peak margin year. Book growth stays modest because buybacks absorb most retained earnings, and the terminal rate of 3.5% is below the 4.99% risk-free rate. Nothing in the new data justifies changing the beta or the failure probability for a low-leverage broker.
Value drivers
| Return on equity (normalized) | 19.0% |
| Book-value growth (Y1) | 4.0% |
| Terminal book growth | 3.5% |
| Beta | 0.95 |
| Failure probability | 0.7% |
| Cost of equity | 9.3% |
Valuation bridge
| PV of excess returns | 3.66B |
| PV of terminal excess | 1.65B |
| Equity value | 13.19B |
| ÷ shares → per share | $142.03 |
Projected excess returns on equity
| Yr | Book equity | ROE | Excess return | PV |
|---|---|---|---|---|
| 1 | 7.98B | 19.0% | 776.54M | 710.70M |
| 2 | 8.30B | 18.1% | 736.30M | 616.74M |
| 3 | 8.62B | 17.3% | 691.23M | 529.90M |
| 4 | 8.96B | 16.4% | 641.12M | 449.81M |
| 5 | 9.30B | 15.6% | 585.75M | 376.12M |
| 6 | 9.65B | 14.7% | 524.91M | 308.48M |
| 7 | 10.01B | 13.8% | 458.40M | 246.55M |
| 8 | 10.38B | 13.0% | 385.99M | 190.00M |
| 9 | 10.75B | 12.1% | 307.50M | 138.53M |
| 10 | 11.14B | 11.3% | 222.72M | 91.83M |
Key risks
- A softening commercial P&C pricing cycle reduces commission growth and squeezes margins
- Heavy buybacks and goodwill leave tangible book negative and add leverage, so the business has less cushion in a downturn
- Organic growth slows in Health, Wealth & Career consulting, and there is execution risk in portfolio reshaping and M&A
Catalysts
- Margin expansion holds above 22%, with mid-single-digit organic growth
- Large buybacks continue and lift EPS even if book equity stays flat